Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation: Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study

被引：0
|
作者：
Lehto, M. [1 ]
Luojus, A. [1 ]
Halminen, O. [2 ]
Haukka, J. [3 ]
Lehtonen, O. [2 ]
Tiili, P.
Aro, A. L. [1 ]
Putaala, J. [1 ]
Linna, M. [4 ]
Mustonen, P. [5 ]
Kinnunen, J. [1 ]
Niemi, M.
Hartikainen, J. [6 ]
Airaksinen, K. E. J.
机构：
[1] Helsinki Univ Hosp, Helsinki, Finland
[2] Aalto Univ, Espoo, Finland
[3] Univ Helsinki, Helsinki, Finland
[4] Univ Eastern Finland, Kuopio, Finland
[5] Turku Univ Hosp, Turku, Finland
[6] Kuopio Univ Hosp, Kuopio, Finland
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clinical characteristics and prognosis of ischemic stroke/transient ischemic attack patients with non-valvular atrial fibrillation not eligible for large trials of direct oral anticoagulants: SAMURAI-NVAF study
    Kumamoto, M.
    Sato, S.
    Koga, M.
    Todo, K.
    Terasaki, T.
    Kamiyama, K.
    Kimura, K.
    Yagita, Y.
    Fujita, K.
    Ando, D.
    Kamimura, T.
    Yashimoto, T.
    Ide, T.
    Matsubara, S.
    Shiozawa, M.
    Yamaguchi, Y.
    Yamagami, H.
    Yoshimura, S.
    Arihiro, S.
    Toyoda, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 874 - 874
  • [42] Long term follow up of direct oral anticoagulants and warfarin therapy on stroke, with all-cause mortality as a competing risk, in people with atrial fibrillation: Sentinel network database study
    De Lusignan, Simon
    Hobbsid, F. D. Richard
    Liyanage, Harshana
    Sherlock, Julian
    Ferreira, Filipa
    Tripathy, Manasa
    Heiss, Christian
    Feher, Michael
    Joy, Mark P.
    PLOS ONE, 2022, 17 (09):
  • [43] Effectiveness and Safety of Standard and Reduced Dose Non-Vitamin K Oral Anticoagulants versus Warfarin in Non-Valvular Atrial Fibrillation - An International Comparative Cohort Study in the Scandinavian Countries
    Johnsen, Soren P.
    Madsen, Morten
    Linder, Marie
    Sulo, Gerhard
    Ghanima, Waleed
    Gislason, Gunnar H.
    Halvorsen, Sigrun
    Hohnloser, Stefan H.
    Jenkins, Aaron
    Al-Khalili, Faris
    Tell, Grethe S.
    Ehrenstein, Vera
    CIRCULATION, 2019, 140
  • [44] Prior direct oral anticoagulant dosage and outcomes in patients with acute ischemic stroke and non-valvular atrial fibrillation: A sub-analysis of PASTA registry study
    Mashiko, Takafumi
    Fujimoto, Shigeru
    Suda, Satoshi
    Abe, Arata
    Iguchi, Yasuyuki
    Yagita, Yoshiki
    Kanzawa, Takao
    Okubo, Seiji
    Todo, Kenichi
    Yamazaki, Mineo
    Nakajima, Nobuhito
    Kondo, Kimito
    Inoue, Takeshi
    Iwanaga, Takeshi
    Terasawa, Yuka
    Shibazaki, Kensaku
    Kimura, Kazumi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 434
  • [45] CLINICAL EFFECTIVENESS AND SAFETY OF STANDARD-DOSE AND LOW-DOSE NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: A NATIONWIDE POPULATION-BASED COHORT STUDY
    Yun, J. E.
    VALUE IN HEALTH, 2018, 21 : S359 - S359
  • [46] Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study
    Kimura, Shunsuke
    Toyoda, Kazunori
    Yoshimura, Sohei
    Minematsu, Kazuo
    Yasaka, Masahiro
    Paciaroni, Maurizio
    Werring, David J.
    Yamagami, Hiroshi
    Nagao, Takehiko
    Yoshimura, Shinichi
    Polymeris, Alexandros
    Zietz, Annaelle
    Engelter, Stefan T.
    Kallmuenzer, Bernd
    Cappellari, Manuel
    Chiba, Tetsuya
    Yoshimoto, Takeshi
    Shiozawa, Masayuki
    Kitazono, Takanari
    Koga, Masatoshi
    STROKE, 2022, 53 (05) : 1540 - 1549
  • [47] Confidence in the Use of Direct Oral Anticoagulants in the Acute Phase of Nonvalvular Atrial Fibrillation-Related Ischemic Stroke Over the Years: A Real-World Single-Center Study
    Moroni, Federico
    Masotti, Luca
    Vannucchi, Vieri
    Chiarelli, Raffaella
    Seravalle, Cristiana
    Pesci, Alessandra
    Pallini, Francesca
    Puliti, Silvia
    Cimolato, Barbara
    Fattorini, Lamberto
    Scerra, Cornelia
    Ristori, Francesca
    Imbalzano, Maria Letizia
    Spolveri, Stefano
    Landini, Giancarlo
    Grifoni, Elisa
    Paciaroni, Maurizio
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (01): : 76 - 82
  • [48] Topic: AS23 Stroke Prevention (primary and secondary) EFFECTS OF DIRECT ORAL ANTICOAGULANTS NON-RECOMMENDED DOSE IN ATRIAL FIBRILLATION. PROSPECTIVE STUDY AND META-ANALYSIS
    Mosconi, M. G.
    Maraziti, G.
    Caso, V.
    Paciaroni, M.
    Vedovati, M. C.
    Bogliari, G.
    Urbini, C.
    Traballi, L.
    Giustozzi, M.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (2_SUPPL) : 85 - 85
  • [49] Clinical Efficacy and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients with Non-Valvular Atrial Fibrillation: Results from a Nationwide Cohort Study
    Cho, M. S.
    Yun, J. E.
    Park, J. J.
    Kim, Y. J.
    Lee, J.
    Park, D. W.
    Nam, G. B.
    EUROPEAN HEART JOURNAL, 2018, 39 : 205 - 205
  • [50] ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAI<spacing diaeresis>VE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
    Gennaro, N.
    Ferroni, E.
    Zorzi, M.
    Denas, G.
    Pengo, V.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 394
12345